The vector of anti-TF chimeric antigen receptor (CAR) is constructed for the engineering of T cells to target human TF. The T cells are genetically modified through transduction with a lentiviral vector expressing hFVIIL linked to CD28 signaling domains. And the vector product was designed for the modifying T cell, modified T cells for the treatment of tumors.
For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.
|CAR-T-1-L406-G||TF h(FcεRIγ) CAR, [T]|
|CAR-T-3-L406-2BZ||TF h(CD28-41BB-CD3ζ) CAR, [T]|
|CAR-T-2-L406-CZ||TF h(b2c-CD3ζ) CAR, [T]|
|CAR-T-3-L406-2XZ||TF h(CD28-OX40-CD3ζ) CAR, [T]|
|CAR-T-2-L406-BZ||TF h(41BB-CD3ζ) CAR, [T]|
|CAR-T-2-L406-8Z||TF h(CD8-CD3ζ) CAR, [T]|
|CAR-T-2-L406-2G||TF h(CD28-FcεRIγ) CAR, [T]|
|CAR-T-2-L406-4G||TF h(CD4-FcεRIγ) CAR, [T]|
|CAR-T-2-L406-2Z||TF h(CD28-CD3ζ) CAR, [T]|
|VP-TCR-C526||Lenti-TF T cell receptor (D10) Viral Particle|
Copyright © 2007 - 2018 Creative Biolabs. All Rights Reserved